Page 79 - AN-1-2
P. 79

Advanced Neurology                                               NMDA receptors in neuropsychiatric diseases



                Bioorg Med Chem Lett, 12: 1099–1102.           185.  Fischer G,  et al., 1997, Ro 25-6981, a highly potent and
                                                                   selective blocker of N-methyl-D-aspartate receptors
                https://doi.org/1016/s0960-894x(02)00074-4
                                                                   containing the NR2B subunit. Characterization  in vitro.
            175.  Hood WF, Sun ET, Compton RP,  et  al., 1989,     J Pharmacol Exp Ther, 283: 1285–1292.
                1-Aminocyclobutane-1-carboxylate (ACBC): A  specific
                antagonist of the N-methyl-D-aspartate receptor coupled   186.  Bettini  E,  Sava  A,  Griffante  C,  et al.,  2010,  Identification
                glycine receptor. Eur J Pharmacol, 161: 281–282.   and characterization of novel NMDA receptor antagonists
                                                                   selective  for  NR2A-  over  NR2B-containing  receptors.
                https://doi.org/1016/0014-2999(89)90861-3          J Pharmacol Exp Ther, 335: 636–644.
            176.  Kemp JA, Foster AC, Leeson PD,  et al., 1988,      https://doi.org/1124/jpet.110.172544
                7-Chlorokynurenic acid is a selective antagonist at the
                glycine modulatory site of the N-methyl-D-aspartate   187.  Hansen KB, Ogden KK, Traynelis SF, 2012, Subunit-selective
                receptor complex. Proc Natl Acad Sci U S A, 85: 6547–6550.   allosteric inhibition of glycine binding to NMDA receptors.
                                                                   J Neurosci, 32: 6197–6208.
                https://doi.org/1073/pnas.85.17.6547
                                                                   https://doi.org/1523/JNEUROSCI.5757-11.2012
            177.  Davies  J,  Watkins  JC,  1972,  Is  1-hydroxy-3-
                aminopyrrolidone-2 (HA-966) a selective excitatory amino-  188.  Edman S, McKay S, MacDonald LJ, et al., 2012, TCN 201
                acid antagonist? Nat New Biol, 238: 61–63.         selectively blocks GluN2A-containing NMDARs in a
                                                                   GluN1 co-agonist dependent but non-competitive manner.
                https://doi.org/1038/newbio238061a0                Neuropharmacology, 63: 441–449.
            178.  Priestley T, Laughton P, Macaulay AJ,  et al., 1996,      https://doi.org/1016/j.neuropharm.2012.04.
                Electrophysiological characterisation of the antagonist
                properties  of  two  novel  NMDA  receptor  glycine  site   189.  Mosley CA, Acker TM, Hansen KB, et al., 2010, Quinazolin-
                antagonists, L-695,902 and L-701,324. Neuropharmacology,   4-one derivatives: A  novel class of noncompetitive
                35: 1573–1581.                                     NR2C/D subunit-selective N-methyl-D-aspartate receptor
                                                                   antagonists. J Med Chem, 53: 5476–5490.
                https://doi.org/1016/s0028-3908(96)00141-4
                                                                   https://doi.org/1021/jm100027p
            179.  Anis N, Sherby S, Goodnow R Jr., et al., 1990, Structure-
                activity relationships of philanthotoxin analogs and   190.  Hansen KB, Traynelis SF, 2011, Structural and mechanistic
                polyamines on N-methyl-D-aspartate and nicotinic   determinants of a novel site for noncompetitive inhibition
                acetylcholine receptors. J Pharmacol Exp Ther, 254: 764–773.  of GluN2D-containing NMDA receptors.  J  Neurosci,
                                                                   31: 3650–3661.
            180.  Lodge D, Johnson KM, 1990, Noncompetitive excitatory
                amino acid receptor antagonists.  Trends Pharmacol Sci,      https://doi.org/1523/JNEUROSCI.5565-10.2011
                11: 81–86.                                     191.  Costa BM, Irvine MW, Fang G, et al., 2010, A novel family
                https://doi.org/1016/0165-6147(90)90323-z          of negative and positive allosteric modulators of NMDA
                                                                   receptors. J Pharmacol Exp Ther, 335: 614–621.
            181.  Wong EH, Kemp JA, Priestley T,  et  al., 1986, The
                anticonvulsant MK-801 is a potent N-methyl-D-aspartate      https://doi.org/1124/jpet.110.174144
                antagonist. Proc Natl Acad Sci U S A, 83: 7104–7108.   192.  Costa BM, Irvine MW, Fang G, et al., 2012, Structure-activity
                https://doi.org/1073/pnas.83.18.7104               relationships for allosteric NMDA receptor inhibitors based
                                                                   on 2-naphthoic acid. Neuropharmacology, 62: 1730–1736.
            182.  Carter C, Rivy JP, Scatton B, 1989, Ifenprodil and SL 82.0715
                are antagonists at the polyamine site of the N-methyl-D-     https://doi.org/1016/j.neuropharm.2011.11.019
                aspartate (NMDA) receptor. Eur J Pharmacol, 164: 611–612.   193.  Kloda A, Clements JD, Lewis RJ,  et al., 2004, Adenosine
                https://doi.org/1016/0014-2999(89)90275-6          triphosphate acts as both a competitive antagonist and a
                                                                   positive allosteric modulator at recombinant N-methyl-D-
            183.  Karakas E, Simorowski N, Furukawa H, 2011, Subunit   aspartate receptors. Mol Pharmacol, 65: 1386–1396.
                arrangement and phenylethanolamine binding in GluN1/
                GluN2B NMDA receptors. Nature, 475: 249–253.       https://doi.org/1124/mol.65.6.1386
                https://doi.org/1038/nature10180               194.  Williams K, 1994, Subunit-specific potentiation of
                                                                   recombinant N-methyl-D-aspartate receptors by histamine.
            184.  Chenard BL, Bordner J, Butler TW, et al., 1995, (1S,2S)-1-
                (4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidino)-  Mol Pharmacol, 46: 531–541.
                1-propanol: A  potent new neuroprotectant which   195.  Williams K, Zappia AM, Pritchett DB, et al., 1994, Sensitivity
                blocks N-methyl-D-aspartate responses.  J  Med  Chem,   of the N-methyl-D-aspartate receptor to polyamines is
                38: 3138–3145.                                     controlled by NR2 subunits. Mol Pharmacol, 45: 803–809.
                https://doi.org/1021/jm00016a017               196.  Sedlacek M, Korínek M, Petrovic M, et al., 2008, Neurosteroid


            Volume 1 Issue 2 (2022)                         23                      https://doi.org/10.36922/an.v1i2.148
   74   75   76   77   78   79   80   81   82   83   84